Phenotypical and Pharmacological Characterization of Stem-Like Cells in Human Pituitary Adenomas

Roberto Würth, Federica Barbieri, Alessandra Pattarozzi, Germano Gaudenzi, Federico Gatto, Pietro Fiaschi, Jean Louis Ravetti, Gianluigi Zona, Antonio Daga, Luca Persani, Diego Ferone, Giovanni Vitale, Tullio Florio

Research output: Contribution to journalArticle

Abstract

The presence and functional role of tumor stem cells in benign tumors, and in human pituitary adenomas in particular, is a debated issue that still lacks a definitive formal demonstration. Fifty-six surgical specimens of human pituitary adenomas were processed to establish tumor stem-like cultures by selection and expansion in stem cell-permissive medium or isolating CD133-expressing cells. Phenotypic and functional characterization of these cells was performed (1) ex vivo, by immunohistochemistry analysis on paraffin-embedded tissues; (2) in vitro, attesting marker expression, proliferation, self-renewal, differentiation, and drug sensitivity; and (3) in vivo, using a zebrafish model. Within pituitary adenomas, we identified rare cell populations expressing stem cell markers but not pituitary hormones; we isolated and expanded in vitro these cells, obtaining fibroblast-free, stem-like cultures from 38 pituitary adenoma samples. These cells grow as spheroids, express stem cell markers (Oct4, Sox2, CD133, and nestin), show sustained in vitro proliferation as compared to primary cultures of differentiated pituitary adenoma cells, and are able to differentiate in hormone-expressing pituitary cells. Besides, pituisphere cells, apparently not tumorigenic in mice, engrafted in zebrafish embryos, inducing pro-angiogenic and invasive responses. Finally, pituitary adenoma stem-like cells express regulatory pituitary receptors (D2R, SSTR2, and SSTR5), whose activation by a dopamine/somatostatin chimeric agonist exerts antiproliferative effects. In conclusion, we provide evidence that human pituitary adenomas contain a subpopulation fulfilling biological and phenotypical signatures of tumor stem cells that may represent novel therapeutic targets for therapy-resistant tumors.

Original languageEnglish
Pages (from-to)4879–4895
Number of pages17
JournalMolecular Neurobiology
Volume54
DOIs
Publication statusPublished - Sep 2017

Fingerprint

Pituitary Neoplasms
Stem Cells
Pharmacology
Pituitary Hormones
Neoplastic Stem Cells
Zebrafish
Nestin
Neoplasms
Somatostatin
Paraffin
Dopamine
Embryonic Structures
Fibroblasts
Immunohistochemistry
Therapeutics
Pharmaceutical Preparations
Population
In Vitro Techniques

Keywords

  • Cancer stem cells
  • Cell proliferation
  • Pituitary adenoma
  • Somatostatin receptors
  • Spherogenesis

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience

Cite this

Würth, R., Barbieri, F., Pattarozzi, A., Gaudenzi, G., Gatto, F., Fiaschi, P., ... Florio, T. (2017). Phenotypical and Pharmacological Characterization of Stem-Like Cells in Human Pituitary Adenomas. Molecular Neurobiology, 54, 4879–4895. https://doi.org/10.1007/s12035-016-0025-x

Phenotypical and Pharmacological Characterization of Stem-Like Cells in Human Pituitary Adenomas. / Würth, Roberto; Barbieri, Federica; Pattarozzi, Alessandra; Gaudenzi, Germano; Gatto, Federico; Fiaschi, Pietro; Ravetti, Jean Louis; Zona, Gianluigi; Daga, Antonio; Persani, Luca; Ferone, Diego; Vitale, Giovanni; Florio, Tullio.

In: Molecular Neurobiology, Vol. 54, 09.2017, p. 4879–4895.

Research output: Contribution to journalArticle

Würth, Roberto ; Barbieri, Federica ; Pattarozzi, Alessandra ; Gaudenzi, Germano ; Gatto, Federico ; Fiaschi, Pietro ; Ravetti, Jean Louis ; Zona, Gianluigi ; Daga, Antonio ; Persani, Luca ; Ferone, Diego ; Vitale, Giovanni ; Florio, Tullio. / Phenotypical and Pharmacological Characterization of Stem-Like Cells in Human Pituitary Adenomas. In: Molecular Neurobiology. 2017 ; Vol. 54. pp. 4879–4895.
@article{5a7d73a8885f4eb69d99baaeb6c79eb9,
title = "Phenotypical and Pharmacological Characterization of Stem-Like Cells in Human Pituitary Adenomas",
abstract = "The presence and functional role of tumor stem cells in benign tumors, and in human pituitary adenomas in particular, is a debated issue that still lacks a definitive formal demonstration. Fifty-six surgical specimens of human pituitary adenomas were processed to establish tumor stem-like cultures by selection and expansion in stem cell-permissive medium or isolating CD133-expressing cells. Phenotypic and functional characterization of these cells was performed (1) ex vivo, by immunohistochemistry analysis on paraffin-embedded tissues; (2) in vitro, attesting marker expression, proliferation, self-renewal, differentiation, and drug sensitivity; and (3) in vivo, using a zebrafish model. Within pituitary adenomas, we identified rare cell populations expressing stem cell markers but not pituitary hormones; we isolated and expanded in vitro these cells, obtaining fibroblast-free, stem-like cultures from 38 pituitary adenoma samples. These cells grow as spheroids, express stem cell markers (Oct4, Sox2, CD133, and nestin), show sustained in vitro proliferation as compared to primary cultures of differentiated pituitary adenoma cells, and are able to differentiate in hormone-expressing pituitary cells. Besides, pituisphere cells, apparently not tumorigenic in mice, engrafted in zebrafish embryos, inducing pro-angiogenic and invasive responses. Finally, pituitary adenoma stem-like cells express regulatory pituitary receptors (D2R, SSTR2, and SSTR5), whose activation by a dopamine/somatostatin chimeric agonist exerts antiproliferative effects. In conclusion, we provide evidence that human pituitary adenomas contain a subpopulation fulfilling biological and phenotypical signatures of tumor stem cells that may represent novel therapeutic targets for therapy-resistant tumors.",
keywords = "Cancer stem cells, Cell proliferation, Pituitary adenoma, Somatostatin receptors, Spherogenesis",
author = "Roberto W{\"u}rth and Federica Barbieri and Alessandra Pattarozzi and Germano Gaudenzi and Federico Gatto and Pietro Fiaschi and Ravetti, {Jean Louis} and Gianluigi Zona and Antonio Daga and Luca Persani and Diego Ferone and Giovanni Vitale and Tullio Florio",
year = "2017",
month = "9",
doi = "10.1007/s12035-016-0025-x",
language = "English",
volume = "54",
pages = "4879–4895",
journal = "Molecular Neurobiology",
issn = "0893-7648",
publisher = "Humana Press Inc.",

}

TY - JOUR

T1 - Phenotypical and Pharmacological Characterization of Stem-Like Cells in Human Pituitary Adenomas

AU - Würth, Roberto

AU - Barbieri, Federica

AU - Pattarozzi, Alessandra

AU - Gaudenzi, Germano

AU - Gatto, Federico

AU - Fiaschi, Pietro

AU - Ravetti, Jean Louis

AU - Zona, Gianluigi

AU - Daga, Antonio

AU - Persani, Luca

AU - Ferone, Diego

AU - Vitale, Giovanni

AU - Florio, Tullio

PY - 2017/9

Y1 - 2017/9

N2 - The presence and functional role of tumor stem cells in benign tumors, and in human pituitary adenomas in particular, is a debated issue that still lacks a definitive formal demonstration. Fifty-six surgical specimens of human pituitary adenomas were processed to establish tumor stem-like cultures by selection and expansion in stem cell-permissive medium or isolating CD133-expressing cells. Phenotypic and functional characterization of these cells was performed (1) ex vivo, by immunohistochemistry analysis on paraffin-embedded tissues; (2) in vitro, attesting marker expression, proliferation, self-renewal, differentiation, and drug sensitivity; and (3) in vivo, using a zebrafish model. Within pituitary adenomas, we identified rare cell populations expressing stem cell markers but not pituitary hormones; we isolated and expanded in vitro these cells, obtaining fibroblast-free, stem-like cultures from 38 pituitary adenoma samples. These cells grow as spheroids, express stem cell markers (Oct4, Sox2, CD133, and nestin), show sustained in vitro proliferation as compared to primary cultures of differentiated pituitary adenoma cells, and are able to differentiate in hormone-expressing pituitary cells. Besides, pituisphere cells, apparently not tumorigenic in mice, engrafted in zebrafish embryos, inducing pro-angiogenic and invasive responses. Finally, pituitary adenoma stem-like cells express regulatory pituitary receptors (D2R, SSTR2, and SSTR5), whose activation by a dopamine/somatostatin chimeric agonist exerts antiproliferative effects. In conclusion, we provide evidence that human pituitary adenomas contain a subpopulation fulfilling biological and phenotypical signatures of tumor stem cells that may represent novel therapeutic targets for therapy-resistant tumors.

AB - The presence and functional role of tumor stem cells in benign tumors, and in human pituitary adenomas in particular, is a debated issue that still lacks a definitive formal demonstration. Fifty-six surgical specimens of human pituitary adenomas were processed to establish tumor stem-like cultures by selection and expansion in stem cell-permissive medium or isolating CD133-expressing cells. Phenotypic and functional characterization of these cells was performed (1) ex vivo, by immunohistochemistry analysis on paraffin-embedded tissues; (2) in vitro, attesting marker expression, proliferation, self-renewal, differentiation, and drug sensitivity; and (3) in vivo, using a zebrafish model. Within pituitary adenomas, we identified rare cell populations expressing stem cell markers but not pituitary hormones; we isolated and expanded in vitro these cells, obtaining fibroblast-free, stem-like cultures from 38 pituitary adenoma samples. These cells grow as spheroids, express stem cell markers (Oct4, Sox2, CD133, and nestin), show sustained in vitro proliferation as compared to primary cultures of differentiated pituitary adenoma cells, and are able to differentiate in hormone-expressing pituitary cells. Besides, pituisphere cells, apparently not tumorigenic in mice, engrafted in zebrafish embryos, inducing pro-angiogenic and invasive responses. Finally, pituitary adenoma stem-like cells express regulatory pituitary receptors (D2R, SSTR2, and SSTR5), whose activation by a dopamine/somatostatin chimeric agonist exerts antiproliferative effects. In conclusion, we provide evidence that human pituitary adenomas contain a subpopulation fulfilling biological and phenotypical signatures of tumor stem cells that may represent novel therapeutic targets for therapy-resistant tumors.

KW - Cancer stem cells

KW - Cell proliferation

KW - Pituitary adenoma

KW - Somatostatin receptors

KW - Spherogenesis

UR - http://www.scopus.com/inward/record.url?scp=84981515984&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84981515984&partnerID=8YFLogxK

U2 - 10.1007/s12035-016-0025-x

DO - 10.1007/s12035-016-0025-x

M3 - Article

VL - 54

SP - 4879

EP - 4895

JO - Molecular Neurobiology

JF - Molecular Neurobiology

SN - 0893-7648

ER -